Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
23 Apr 24
6-K
Report of Foreign Private Issuer
15 Apr 24
6-K
Immuron Travelan® sales continued strong growth
10 Apr 24
6-K
Report of Foreign Private Issuer
14 Mar 24
6-K
Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
7 Mar 24
6-K
Report of Foreign Private Issuer
4 Mar 24
6-K
Results for announcement to the market
28 Feb 24
6-K
Report of Foreign Private Issuer
21 Feb 24
6-K
Immuron achieves record Travelan® sales
13 Feb 24
6-K
Investor Webinar Presentation
9 Feb 24
6-K
Immuron achieves record half yearly Travelan® sales
16 Jan 24
6-K
Immuron Clinical Trials Update
22 Dec 23
6-K
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
4 Dec 23
6-K
Investor Webinar Presentation
28 Nov 23
6-K
Report of Foreign Private Issuer
22 Nov 23
6-K
Report of Foreign Private Issuer
21 Nov 23
6-K
Investor Webinar Presentation
13 Nov 23
6-K
Immuron CEO, Steven Lydeamore to present at AusBioInvest
30 Oct 23
6-K
Notice of 2023 Annual General Meeting and 21 November 2023 at 10.00 am
23 Oct 23
6-K
Report of Foreign Private Issuer
18 Oct 23
6-K
Immuron achieves record quarterly Travelan® sales
11 Oct 23
6-K
Report of Foreign Private Issuer
3 Oct 23
6-K
Report of Foreign Private Issuer
28 Sep 23
20-F
2023 FY
Annual report (foreign)
28 Sep 23
6-K
Immuron achieves record monthly Travelan® sales
13 Sep 23
6-K
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
11 Sep 23
6-K
Preliminary Final Report
30 Aug 23
6-K
Immuron to present at the Military Health System Research Symposium
14 Aug 23
6-K
Immuron Receives TGA GMP Clearance
9 Aug 23
6-K
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
24 Jul 23
6-K
Immuron CEO, Steven Lydeamore to present at Bioshares
24 Jul 23
6-K
Report of Foreign Private Issuer
11 Jul 23
6-K
Report of Foreign Private Issuer
5 Jul 23
6-K
Report of Foreign Private Issuer
30 Jun 23
6-K
Report of Foreign Private Issuer
22 Jun 23
6-K
Immuron CEO, Steven Lydeamore presents at LD Micro
7 Jun 23
6-K
Report of Foreign Private Issuer
30 May 23
6-K
Report of Foreign Private Issuer
8 May 23
6-K
Report of Foreign Private Issuer
2 May 23
6-K
Q3 FY23 Business Update Presentation
19 Apr 23